共 50 条
- [42] Pathological complete response and survival of HER2-positive invasive breast cancer following docetaxel, carboplatin, and trastuzumab neoadjuvant therapy: a Vietnamese experience ONCOLOGY IN CLINICAL PRACTICE, 2023, 19 (04): : 235 - 243
- [47] Therapy for HER2-Positive Metastatic Breast Cancer REPLY NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25):